Marian Stevens‐Kroef

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst et al. · Blood · 2010 · 338 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Optical genome mapping enables constitutional chromosomal aberration detection

Tuomo Mantere, Kornelia Neveling, Céline Pebrel‐Richard et al. · The American Journal of Human Genetics · 2021 · 253 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Hartmut Goldschmidt, H M Lokhorst, E K et al. · Leukemia · 2017 · 201 citations · Full text

Medicine, Hematology, Oncology +14

Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping

Kornelia Neveling, Tuomo Mantere, Susan Vermeulen et al. · The American Journal of Human Genetics · 2021 · 200 citations · Full text

Life Sciences, Genetics, Hematology +17